1.28
-0.10 (-6.93%)
| Previous Close | 1.37 |
| Volume | 1,972,744 |
| Price / Sales | 13.41 |
| Price / Book | 1.57 |
| 52 Weeks Range |
| Operating Margin (TTM) | -1,823.76% |
| Diluted EPS (TTM) | -1.62 |
| Quarterly Revenue Growth (YOY) | -3.10% |
| Total Debt/Equity (MRQ) | 12.07% |
| Current Ratio (MRQ) | 7.63 |
| Operating Cash Flow (TTM) | -137.72 M |
| Levered Free Cash Flow (TTM) | -82.51 M |
| Return on Assets (TTM) | -29.21% |
| Return on Equity (TTM) | -52.76% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | Caribou Biosciences, Inc. | Mixed | Bullish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -2.5 |
| Average | -0.67 |
|
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Value |
| % Held by Insiders | 9.83% |
| % Held by Institutions | 53.66% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |